Erratum to “Gut Microbiota Modulation by Lysozyme as a Key Regulator of Vascular Inflammatory Aging”

Key Points

• The aim is to clarify the findings regarding the role of lysozyme in gut microbiota modulation and its impact on vascular inflammatory aging.
• Correction of previously reported findings.
• Review of lysozyme's effects on gut microbiota composition.
• Assessment of vascular inflammation markers related to aging.
• Clarification of lysozyme's role as a modulator in gut microbiota.
• Updated insights into the link between gut microbiota and vascular aging.